NYSE:CBM - Cambrex Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cambrex Co. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $59.99 0.00 (0.00 %) (As of 01/27/2020) Add Compare Today's Range$59.99Now: $59.99▼$59.9950-Day Range$59.99MA: $59.99▼$59.9952-Week Range$33.80Now: $59.99▼$60.29VolumeN/AAverage Volume218,726 shsMarket Capitalization$2.02 billionP/E Ratio21.66Dividend YieldN/ABeta2.14 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. Its products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products, as well as finished dosage forms. Read More… Industry, Sector and Symbol Stock Exchange NYSE Industry Pharmaceutical preparations Sub-IndustryLife Sciences Tools & Services SectorMedical Current SymbolNYSE:CBM Previous Symbol CUSIP13201110 CIK820081 Webhttp://www.cambrex.com/ Phone201-804-3000Debt Debt-to-Equity Ratio0.76 Current Ratio2.37 Quick Ratio1.70Price-To-Earnings Trailing P/E Ratio21.66 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$532.09 million Price / Sales3.80 Cash Flow$3.91 per share Price / Cash Flow15.36 Book Value$19.48 per share Price / Book3.08Profitability EPS (Most Recent Fiscal Year)$2.77 Net Income$92.41 million Net Margins5.96% Return on Equity5.38% Return on Assets2.50%Miscellaneous Employees1,732 Outstanding Shares33,720,000Market Cap$2.02 billion Next Earnings DateN/A OptionableOptionable Receive CBM News and Ratings via Email Sign-up to receive the latest news and ratings for CBM and its competitors with MarketBeat's FREE daily newsletter. CBM Rates by TradingView Cambrex (NYSE:CBM) Frequently Asked Questions What is Cambrex's stock symbol? Cambrex trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBM." How were Cambrex's earnings last quarter? Cambrex Co. (NYSE:CBM) posted its quarterly earnings data on Thursday, August, 2nd. The biotechnology company reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.05. The biotechnology company earned $152.05 million during the quarter, compared to analysts' expectations of $132.78 million. Cambrex had a return on equity of 5.38% and a net margin of 5.96%. Cambrex's revenue for the quarter was up 13.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.76 earnings per share. View Cambrex's Earnings History. What price target have analysts set for CBM? 5 brokerages have issued 1 year price targets for Cambrex's shares. Their forecasts range from $43.00 to $60.00. On average, they anticipate Cambrex's stock price to reach $52.40 in the next twelve months. This suggests that the stock has a possible downside of 12.7%. View Analyst Price Targets for Cambrex. What is the consensus analysts' recommendation for Cambrex? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cambrex in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cambrex. Has Cambrex been receiving favorable news coverage? Media coverage about CBM stock has trended neutral on Wednesday, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cambrex earned a media sentiment score of 0.5 on InfoTrie's scale. They also assigned press coverage about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Cambrex. Who are some of Cambrex's key competitors? Some companies that are related to Cambrex include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Charles River Laboratories Intl. (CRL), BIO-TECHNE (TECH), Bruker (BRKR), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE). What other stocks do shareholders of Cambrex own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cambrex investors own include Celgene (CELG), Illumina (ILMN), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), NVIDIA (NVDA), Intel (INTC), Under Armour (UAA), Broadcom (AVGO) and Juno Therapeutics (JUNO). Who are Cambrex's key executives? Cambrex's management team includes the folowing people: Mr. Steven M. Klosk, Pres, CEO & Director (Age 62)Mr. Gregory P. Sargen, Exec. VP of Corp. Devel. & Strategy and CFO (Age 53)Mr. Shawn P. Cavanagh, Exec. VP & COO (Age 53)Ms. Samantha M. Hanley, VP, Gen. Counsel & Corp. Sec. (Age 41)Mr. James G. Farrell, VP & Corp. Controller (Age 52) How do I buy shares of Cambrex? Shares of CBM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Cambrex's stock price today? One share of CBM stock can currently be purchased for approximately $59.99. How big of a company is Cambrex? Cambrex has a market capitalization of $2.02 billion and generates $532.09 million in revenue each year. The biotechnology company earns $92.41 million in net income (profit) each year or $2.77 on an earnings per share basis. Cambrex employs 1,732 workers across the globe.View Additional Information About Cambrex. What is Cambrex's official website? The official website for Cambrex is http://www.cambrex.com/. How can I contact Cambrex? Cambrex's mailing address is ONE MEADOWLANDS PLZ, EAST RUTHERFORD NJ, 07073. The biotechnology company can be reached via phone at 201-804-3000 or via email at [email protected] MarketBeat Community Rating for Cambrex (NYSE CBM)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 301 (Vote Outperform)Underperform Votes: 292 (Vote Underperform)Total Votes: 593MarketBeat's community ratings are surveys of what our community members think about Cambrex and other stocks. Vote "Outperform" if you believe CBM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBM will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/19/2020 by MarketBeat.com StaffFeatured Article: Why do earnings reports matter?
